These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2857679

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Beta blockers in migraine prophylaxis].
    Shimizu T.
    Brain Nerve; 2009 Oct; 61(10):1125-30. PubMed ID: 19882938
    [Abstract] [Full Text] [Related]

  • 4. Migraine and beta-blockade: modulation of sympathetic neurotransmission.
    Ablad B, Dahlöf C.
    Cephalalgia; 1986 Oct; 6 Suppl 5():7-13. PubMed ID: 2879634
    [Abstract] [Full Text] [Related]

  • 5. [Interval therapy of migraine. Pharmacological bases].
    Ziegler A.
    Fortschr Med; 1984 Mar 29; 102(12):328-32. PubMed ID: 6143715
    [Abstract] [Full Text] [Related]

  • 6. [Drug therapy of migraine].
    Pfaffenrath V, Reiter M.
    Wien Med Wochenschr; 1988 Dec 31; 138(23-24):591-9. PubMed ID: 2906193
    [Abstract] [Full Text] [Related]

  • 7. Comparative review of beta-blocking agents.
    Jackson EA, Sullman SA.
    Conn Med; 1984 Apr 31; 48(4):213-5. PubMed ID: 6143648
    [No Abstract] [Full Text] [Related]

  • 8. Current trends in migraine prophylaxis.
    Ramadan NM.
    Headache; 2007 Apr 31; 47 Suppl 1():S52-7. PubMed ID: 17425710
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Managing the attacks, preventing headache. Migraine therapy in 2002].
    Göbel H, Heinze A, Heinze-Kuhn K.
    MMW Fortschr Med; 2002 May 06; Suppl 2():43-50. PubMed ID: 12070849
    [Abstract] [Full Text] [Related]

  • 12. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ, Schalekamp MA.
    Postgrad Med J; 1983 May 06; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Symptomatic and prophylactic treatment of migraine: a critical reappraisal.
    Deleu D, Hanssens Y, Worthing EA.
    Clin Neuropharmacol; 1998 May 06; 21(5):267-79. PubMed ID: 9789706
    [Abstract] [Full Text] [Related]

  • 15. [Adrenergic betablockers].
    Alvarez Sabín J.
    Rev Neurol; 1995 May 06; 23 Suppl 2():S185-9. PubMed ID: 7497284
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical aspects of beta-blockade.
    Smith U.
    Cephalalgia; 1986 May 06; 6 Suppl 5():55-7. PubMed ID: 2879633
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ, High J, DeForrest JM, Sybertz E.
    J Pharmacol Exp Ther; 1986 Jul 06; 238(1):378-87. PubMed ID: 2873238
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of beta-blockade on platelet function and fibrinolytic activity.
    Winther K.
    J Cardiovasc Pharmacol; 1987 Jul 06; 10 Suppl 2():S94-8; discussion S99. PubMed ID: 2481178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.